(Q53128890)

English

Targeting oncogenic drivers and the immune system in melanoma.

scientific article published on 17 December 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

title

Targeting oncogenic drivers and the immune system in melanoma. (English)

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

author

Grant McArthur

series ordinal

1

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

Antoni Ribas

series ordinal

2

object named as

Antoni Ribas

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

language of work or name

English

0 references

publication date

17 December 2012

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

volume

31

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

issue

4

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

page(s)

499-506

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

cites work

A comprehensive catalogue of somatic mutations from a human cancer genome

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE08658

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Mutations of the BRAF gene in human cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

DOI

10.1200/JCO.2012.45.5568

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

Fatcat ID

release_hpegqsuarfeqxpoz7jgilixxhe

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/hpegqsuarfeqxpoz7jgilixxhe

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

23248252

1 reference

stated in

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23248252

(Q53128890)

Targeting oncogenic drivers and the immune system in melanoma.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)